Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Lennartz

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Cancers|December 30, 2025
Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor OutcomesHenning Plage, Nadine Biernath, Kira Furlano, et al.
Neoplasia (New York, N.Y.)|June 24, 2025
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomyNatalia Gorbokon, Seyma Büyücek, Henning Plage, et al.
Pathology, Research and Practice|September 22, 2022
Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumorsRia Uhlig, Karin Günther, Nina Bröker, et al.
Biomedicines|October 27, 2022
Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 TumorsSören Weidemann, Nessar Ahmad Noori, Maximilian Lennartz, et al.
Human Pathology|June 8, 2021
Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumorsAnne Menz, Rifka Bauer, Martina Kluth, et al.
Pathology, Research and Practice|November 14, 2022
Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumorsFlorian Viehweger, Ahmad Azem, Natalia Gorbokon, et al.
Medical Image Analysis|November 27, 2025
A systematic analysis of the impact of data variation on AI-based histopathological grading of prostate cancerPatrick Fuhlert, Fabian Westhaeusser, Esther Dietrich, et al.
Molecular and Cellular Endocrinology|November 11, 2023
Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumorsKatharina Möller, Ria Uhlig, Natalia Gorbokon, et al.
Human Pathology|September 24, 2022
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladderHenning Plage, Henrik Samtleben, Sebastian Hofbauer, et al.
Pathology, Research and Practice|October 30, 2021
DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samplesKristina Jansen, Nagina Farahi, Franziska Büscheck, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Cancers|December 30, 2025
Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor OutcomesHenning Plage, Nadine Biernath, Kira Furlano, et al.
Neoplasia (New York, N.Y.)|June 24, 2025
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomyNatalia Gorbokon, Seyma Büyücek, Henning Plage, et al.
Pathology, Research and Practice|September 22, 2022
Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumorsRia Uhlig, Karin Günther, Nina Bröker, et al.
Biomedicines|October 27, 2022
Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 TumorsSören Weidemann, Nessar Ahmad Noori, Maximilian Lennartz, et al.
Human Pathology|June 8, 2021
Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumorsAnne Menz, Rifka Bauer, Martina Kluth, et al.
Pathology, Research and Practice|November 14, 2022
Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumorsFlorian Viehweger, Ahmad Azem, Natalia Gorbokon, et al.
Medical Image Analysis|November 27, 2025
A systematic analysis of the impact of data variation on AI-based histopathological grading of prostate cancerPatrick Fuhlert, Fabian Westhaeusser, Esther Dietrich, et al.
Molecular and Cellular Endocrinology|November 11, 2023
Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumorsKatharina Möller, Ria Uhlig, Natalia Gorbokon, et al.
Human Pathology|September 24, 2022
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladderHenning Plage, Henrik Samtleben, Sebastian Hofbauer, et al.
Pathology, Research and Practice|October 30, 2021
DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samplesKristina Jansen, Nagina Farahi, Franziska Büscheck, et al.
Pageof 12